Old Web
English
Sign In
Acemap
>
authorDetail
>
Chang Yong Hu
Chang Yong Hu
Tecom
Pracinostat
Histone deacetylase inhibitor
Pharmacology
Pharmacokinetics
Bioavailability
2
Papers
124
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Preclinical metabolism and disposition of SB939 (Pracinostat), an orally active histone deacetylase inhibitor, and prediction of human pharmacokinetics.
2011
Drug Metabolism and Disposition
Ramesh Jayaraman
Venkatesh Pilla Reddy
Mohammed Khalid Pasha
Haishan Wang
Kanda Sangthongpitag
Pauline Yeo
Chang Yong Hu
Xiaofeng Wu
Liu Xin
Evelyn Goh
Lee Sun New
Kantharaj Ethirajulu
Show All
Source
Cite
Save
Citations (19)
SB939, a novel potent and orally active histone deacetylase inhibitor with high tumor exposure and efficacy in mouse models of colorectal cancer.
2010
Molecular Cancer Therapeutics
Veronica Novotny-Diermayr
Kanda Sangthongpitag
Chang Yong Hu
Xiaofeng Wu
Nina Sausgruber
Pauline Yeo
Gediminas Greicius
Sven Pettersson
Ai Leng Liang
Yung Kiang Loh
Zahid Bonday
Kee Chuan Goh
Hannes Hentze
Stefan Hart
Haishan Wang
Kantharaj Ethirajulu
Jeanette Marjorie Wood
Show All
Source
Cite
Save
Citations (105)
1